Miyares. Comment: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy. Ann Pharmacother. 2015;49:612-613.
2.
VermaALevineMShalanskySCarterCKeltonJ. Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy. 2003;23:745-753.
SpencerFAEmeryCLessardD. The Worchester Venous Thromboembolism Study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006;21:722-727.
